NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress

被引：0

作者：

Khasraw, Mustafa ^{[1
,2
]}

McDonald, Kerrie L. ^{[3
]}

Yip, Sonia ^{[4
]}

Verhaak, Roel ^{[5
]}

Heimberger, Amy ^{[6
]}

Hall, Merryn ^{[1
]}

Fisher, Lauren ^{[1
]}

Barnes, Elizabeth ^{[1
]}

Rosenthal, Mark ^{[7
]}

Gedye, Craig ^{[8
]}

Hovey, Elizabeth ^{[9
]}

Ellingson, Benjamin M. ^{[10
]}

Simes, John ^{[1
]}

Tongela, Annette ^{[11
]}

Wheeler, Helen ^{[2
]}

Koh, Eng-Siew ^{[12
]}

Gan, Hui ^{[13
]}

Back, Michael ^{[2
]}

Lwin, Zarnie ^{[14
,15
]}

机构：

[1] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia

[2] Royal North Shore Hosp, St Leonards, NSW, Australia

[3] Univ New South Wales, Kensington, NSW, Australia

[4] Univ Sydney, Sydney Catalyst Translat Canc Res Ctr, Camperdown, NSW, Australia

[5] Jackson Lab Genom Med, Farmington, CT USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[7] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[8] Calvary Mater Newcastle, Waratah, NSW, Australia

[9] Prince Wales Hosp, Randwick, NSW, Australia

[10] Univ Calif Los Angeles, BTIL, Los Angeles, CA USA

[11] Campbelltown Hosp, Campbelltown, NSW, Australia

[12] Liverpool Hosp, Liverpool, NSW, Australia

[13] Austin Hosp, Heidelberg, Vic, Australia

[14] Royal Brisbane Hosp, Brisbane, Qld, Australia

[15] Univ Queensland, Brisbane, Qld, Australia

来源：

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

415

引用

页码：196 / 197

页数：2

共 50 条

[21] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Lazaridis, L.
Schaefer, N.
Kebir, S.
Weller, J.
Tzaridis, T.
Schaeffler, B.
Pierscianek, D.
Kleinschnitz, C.
Stuschke, M.
Sure, U.
Herrlinger, U.
Glas, M.
NEURO-ONCOLOGY, 2018, 20 : 230 - 230
[22] Outcome of grade 3 and 4 cytopenia in newly diagnosed glioblastoma multiforme (GBM) patients treated with temozolomide (TMZ).
Sanchez, B. E.
Munoz, J.
Ali, H. Y.
Anderson, J. M.
Kuriakose, P.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[23] PHASE 1 STUDY EVALUATING ABT-414 WITH CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Gan, H. K.
Fichtel, L.
Lassman, A.
Merrell, R.
van den Bent, M. J.
Kumthekar, P.
Scott, A.
Pedersen, M.
Gomez, E.
Fischer, J.
Ames, W.
Xiong, H.
Dudley, M.
Roberts-Rapp, L.
Ansell, P. J.
Holen, K.
Reardon, D. A.
ANNALS OF ONCOLOGY, 2014, 25
[24] Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM)
Vredenburgh, J. J.
Desjardins, A.
Reardon, D. A.
Peters, K.
Kirkpatrick, J.
Herndon, J. E.
Marcello, J.
Bailey, L.
Threatt, S.
Friedman, H. S.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[25] A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose-dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
Clarke, Jennifer
Sul, Joohee
DeAngelis, Lisa
Lassman, Andrew
Hormigo, Adilia
Nolan, Craig
Gavrilovic, Igor
Gu, Bin
Panageas, Kathy
Abrey, Lauren
NEURO-ONCOLOGY, 2007, 9 (04) : 530 - 530
[26] Analysis of RTOG-RPA Scores in the Phase 3 EF-14 Trial of Tumor Treating Fields with Temozolomide (TTFields/TMZ) Versus TMZ Alone in Newly Diagnosed Glioblastoma.
Choe, K.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S48 - S48
[27] PSEUDOPROGRESSION (PSPR) AFTER CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
Clarke, Jennifer
Abrey, Lauren
Karimi, Sasan
Lassman, Andrew
NEURO-ONCOLOGY, 2008, 10 (05) : 893 - 893
[28] BIOMARKER IMMUNE CORRELATES IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ATEZOLIZUMAB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION
Weathers, Shiao-Pei
Knafl, Mark
Parra, Edwin
Hernandez, Sharia
Solis, Luisa
Espiridion, Beatriz Sanchez
Wistuba, Ignacio
Futreal, Andrew
Maru, Dipen
Kamiya-Matsuoka, Carlos
Harrison, Rebecca
Joseph, Victory
Yun, Cindy
Darbonne, Walter
Loghin, Monica
Penas-Prado, Marta
Majd, Nazanin
Yung, W. K. Alfred
O'Brien, Barbara
Scott, Woodman
DeGroot, John
NEURO-ONCOLOGY, 2021, 23 : 49 - 49
[29] Pseudoprogression (PsPr) after concurrent radiotherapy (RT) and temozolomide (TMZ) for newly diagnosed glioblastoma multiforme (GBM)
Clarke, J. L.
Abrey, L. E.
Karimi, S.
Lassman, A. B.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[30] Randomized phase II trial of erlotinib (E) versus temozolomide (TMZ) or BCNU in recurrent glioblastoma multiforme (GBM): EORTC 26034
Van den Bent, Martin
Brandes, Alba
Rampling, Roy
Kouwenhoven, Mathilde
Kros, Johan M.
Carpentier, Antoine
Clement, Paul
Klughammer, Barbara
Bakker, Brenda
Lacombe, Denis
Gorlia, Thierry
NEURO-ONCOLOGY, 2007, 9 (04) : 522 - 522

← 1 2 3 4 5 →